Steven Gudis
Nephrology · Randolph, NJNPI 1396719845
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $581 and has fallen 56.8% since, to $251 in 2022.
Across 121 payments — averaging $14.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$233
- Amgen$193
- AstraZeneca$189
- Otsuka America Pharmaceutical, Inc.$129
- Bayer$120
- Lilly USA, LLC$107
- plus $761 from 20 others
What the payments were for
- Food & beverage$1,71899%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 17 | $233 |
| Amgen(2 entities) | 14 | $193 |
| AstraZeneca | 14 | $189 |
| Otsuka America Pharmaceutical, Inc. | 9 | $129 |
| Bayer | 7 | $120 |
| Lilly USA, LLC | 8 | $107 |
| Merck | 8 | $97 |
| Akebia Therapeutics Inc | 4 | $91 |
| Pfizer | 5 | $74 |
| Vifor Pharma, Inc. | 4 | $59 |
| Avanir Pharmaceuticals, Inc. | 4 | $57 |
| Ultragenyx Pharmaceutical Inc. | 3 | $43 |
| AbbVie | 3 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $39 |
| ANI Pharmaceuticals, Inc. | 2 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Mallinckrodt Hospital Products Inc. | 2 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Biohaven Pharmaceuticals, Inc. | 2 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Novartis | 1 | $18 |
| Boehringer Ingelheim | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Kaleo, Inc. | 1 | $12 |
| Aurinia Pharma U.S., Inc. | 1 | $12 |
How this compares
$1,732 in reported general payments places this provider in the 60th percentile of 413 nephrology providers in New Jersey.
Other nephrology in Randolph
- Lawrence ByrdLivingston$338K
- Jeffrey FeldmanUnion$315K
- Joshua KaplanNewark$154K
- Vadim FinkielsteinPrinceton Junction$139K
- Neeraj SinghNew Brunswick$133K
- Harry DounisNeptune$75K
- Kenneth LissEatontown$75K
- Jeffrey GoodmanFlorham Park$70K
- Arif AsifNeptune$42K
- Joseph AlbaneseBrick$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.